The FTC Warned 24 Large Healthcare Companies That Following CMS Price Rules Is No Shield Against a Deception Case
A hospital can meet every CMS posting rule and still face an FTC deception case over the estimate a patient receives.
A hospital can meet every CMS posting rule and still face an FTC deception case over the estimate a patient receives.
The drug file reaches manufacturers, and the schema due around May 2027 decides how much net price becomes public.
France has moved the reimbursement threat from price to presence: a competitor’s launch can now put an incumbent under review.
The default gets shorter, and the route back to the maximum runs through comparative trials and filing early in Europe.
The pledge sets a direction without a single measure, target or date. The lever that will matter is managed care procurement.
Constitutional challenges to Medicare negotiation have failed repeatedly. AbbVie is now betting on the definition of its product.
The court did not rule on what AXIOFILL is. It ruled that FDA had not treated like wound care products alike.
Congress named who is medically frail. CMS’s rule decides who can prove it, and the new lawsuit is about that gap.
CMS frames this as fraud recovery. Its release says much less about the 760,000 people whose marketplace coverage ends.
CMS expects much of the coverage loss to come from process, not from failing the test. The insurer asked doctors to help.